A.J. Cumber

776 total citations
19 papers, 632 citations indexed

About

A.J. Cumber is a scholar working on Immunology, Biotechnology and Molecular Biology. According to data from OpenAlex, A.J. Cumber has authored 19 papers receiving a total of 632 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Immunology, 13 papers in Biotechnology and 7 papers in Molecular Biology. Recurrent topics in A.J. Cumber's work include Toxin Mechanisms and Immunotoxins (16 papers), Transgenic Plants and Applications (13 papers) and Monoclonal and Polyclonal Antibodies Research (6 papers). A.J. Cumber is often cited by papers focused on Toxin Mechanisms and Immunotoxins (16 papers), Transgenic Plants and Applications (13 papers) and Monoclonal and Polyclonal Antibodies Research (6 papers). A.J. Cumber collaborates with scholars based in United Kingdom, United States and Switzerland. A.J. Cumber's co-authors include W. C. J. Ross, J.A. Forrester, P E Thorpe, D. C. Edwards, Andrew Davies, N.R. Worrell, Brian M. J. Foxwell, E. Sally Ward, Deirdre P. McIntosh and Gerhard Winter and has published in prestigious journals such as Nature, Blood and The Journal of Immunology.

In The Last Decade

A.J. Cumber

19 papers receiving 568 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
A.J. Cumber United Kingdom	13	443	335	296	199	63	19	632
Edward J. Wawrzynczak United Kingdom	12	332 0.7×	216 0.6×	284 1.0×	169 0.8×	61 1.0×	30	515
Susan L. Bernhard United States	10	171 0.4×	87 0.3×	209 0.7×	197 1.0×	58 0.9×	13	382
David Passmore United States	15	293 0.7×	208 0.6×	424 1.4×	322 1.6×	156 2.5×	24	724
M Borowski United States	8	271 0.6×	207 0.6×	265 0.9×	73 0.4×	70 1.1×	9	642
S Narasimhan Canada	12	293 0.7×	167 0.5×	798 2.7×	142 0.7×	29 0.5×	18	903
Bojana Popovic United Kingdom	15	149 0.3×	119 0.4×	685 2.3×	342 1.7×	36 0.6×	21	1.0k
Brigitte Kaluza Germany	10	133 0.3×	146 0.4×	461 1.6×	83 0.4×	277 4.4×	12	658
E F Hounsell United Kingdom	15	208 0.5×	40 0.1×	582 2.0×	196 1.0×	48 0.8×	17	695
Jérôme Becquart France	10	54 0.1×	67 0.2×	484 1.6×	112 0.6×	62 1.0×	16	597
Pamela H. Gulden United States	8	899 2.0×	49 0.1×	480 1.6×	104 0.5×	301 4.8×	9	1.1k

Countries citing papers authored by A.J. Cumber

Since Specialization

Citations

This map shows the geographic impact of A.J. Cumber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A.J. Cumber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A.J. Cumber more than expected).

Fields of papers citing papers by A.J. Cumber

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A.J. Cumber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A.J. Cumber. The network helps show where A.J. Cumber may publish in the future.

Co-authorship network of co-authors of A.J. Cumber

This figure shows the co-authorship network connecting the top 25 collaborators of A.J. Cumber. A scholar is included among the top collaborators of A.J. Cumber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A.J. Cumber. A.J. Cumber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Zangemeister‐Wittke, Uwe, et al.. (1992). Molecular and biological properties of an abrin A chain immunotoxin designed for therapy of human small cell lung cancer. British Journal of Cancer. 66(2). 361–366. 18 indexed citations

Cumber, A.J., et al.. (1992). Comparative stabilities in vitro and in vivo of a recombinant mouse antibody FvCys fragment and a bisFvCys conjugate. The Journal of Immunology. 149(1). 120–126. 71 indexed citations

Tı́már, József, et al.. (1991). The effect of ricin B chain on the intracellular trafficking of an A chain immunotoxin. British Journal of Cancer. 64(4). 655–662. 17 indexed citations

Skilleter, David N., et al.. (1989). The low uptake of an abrin A-chain immunotoxin by rat hepatic cells in vivo and in vitro. Cancer Letters. 46(3). 161–166. 12 indexed citations

Worrell, N.R., et al.. (1986). Fate of an antibody-ricin a chain conjugate administered to normal rats. Biochemical Pharmacology. 35(3). 417–423. 45 indexed citations

Worrell, N.R., et al.. (1986). Effect of linkage variation on pharmacokinetics of ricin A chain-antibody conjugates in normal rats.. PubMed. 1(3). 179–88. 40 indexed citations

Lowe, J., N. R. Ling, J.A. Forrester, & A.J. Cumber. (1986). Studies on the reappearance of MHC class II antigens on cells of a variant human lymphoblastoid line. Immunology Letters. 12(5-6). 263–269. 2 indexed citations

Cumber, A.J., J.A. Forrester, Brian M. J. Foxwell, W. C. J. Ross, & P E Thorpe. (1985). [16] Preparation of antibody—toxin conjugates. Methods in enzymology on CD-ROM/Methods in enzymology. 112. 207–225. 79 indexed citations

Lowe, J., N. R. Ling, J.A. Forrester, A.J. Cumber, & W. C. J. Ross. (1985). Variants of lymphoid lines produced with ricin A-chain monoclonal antibody conjugates. Journal of Immunological Methods. 76(1). 93–104. 7 indexed citations

10.

Forrester, J.A., et al.. (1984). Delivery of Ricin and Abrin A-Chains to Human Carcinoma Cells in Culture following Covalent Linkage to Monoclonal Antibody LICR-LOND-Fib 75. PubMed. 1(4). 283–292. 24 indexed citations

11.

Thorpe, P E, et al.. (1984). An immunotoxin with therapeutic potential in T cell leukemia: WT1-ricin A. Blood. 63(5). 1178–1185. 47 indexed citations

12.

Thorpe, P E, Simone Detre, Donald W. Mason, A.J. Cumber, & W. C. J. Ross. (1983). Monoclonal Antibody Therapy: “Model” Experiments with Toxin-Conjugated Antibodies in Mice and Rats. Hämatologie und Bluttransfusion. 28. 107–111. 4 indexed citations

13.

McIntosh, Deirdre P., D. C. Edwards, A.J. Cumber, et al.. (1983). Ricin B chain converts a non‐cytotoxic antibody‐ricin A chain conjugate into a potent and specific cytotoxic agent. FEBS Letters. 164(1). 17–20. 59 indexed citations

14.

Edwards, D. C., W. C. J. Ross, A.J. Cumber, et al.. (1982). A comparison of the in vitro and in vivo activities of conjugates of anti-mouse lymphocyte globulin and abrin. Biochimica et Biophysica Acta (BBA) - General Subjects. 717(2). 272–277. 9 indexed citations

15.

Thorpe, P E, Donald W. Mason, A N Brown, et al.. (1982). Selective killing of malignant cells in a leukaemic rat bone marrow using an antibody–ricin conjugate. Nature. 297(5867). 594–596. 74 indexed citations

16.

Edwards, D. C., Adrian L. Smith, W. C. J. Ross, et al.. (1981). The effect of abrin, anti-lymphocyte globulin and their conjugates on the immune response of mice to sheep red blood cells. Cellular and Molecular Life Sciences. 37(3). 256–257. 12 indexed citations

17.

Thorpe, P E, A.J. Cumber, N Williams, et al.. (1981). Abrogation of the non-specific toxicity of abrin conjugated to anti-lymphocyte globulin.. PubMed. 43(1). 195–200. 24 indexed citations

18.

Thorpe, P E, et al.. (1978). Toxicity of diphtheria toxin for lymphoblastoid cells is increased by conjugation to antilymphocytic globulin. Nature. 271(5647). 752–755. 58 indexed citations

19.

Cumber, A.J. & W. C. J. Ross. (1977). Analogues of hexamethylmelamine. The anti-neoplastic activity of derivatives with enhanced water solubility. Chemico-Biological Interactions. 17(3). 349–357. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact